FDA Accepts Valeant-AstraZeneca Psoriasis Application

29.01.2016 - The US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) submitted by UK-Swedish drugmaker AstraZeneca in partnership with Canadian...